The role of the senior responsible officer for patient safety was established to bring together strands of patient safety across NICE, providing a source of advice and oversight accessible throughout the organisation. Last week, the NICE public board meeting considered the
my first annual patient safety update.
The update summarises patient safety matters at NICE from September 2019 to September 2020, during which time the
Independent Medicines and Medical Devices Safety (IMMDS) review was published. The review investigated patient concerns about harmful side effects from medicines and medical devices, focusing on the hormone pregnancy test Primodos, anti-epileptic drug sodium valproate and surgical mesh. However, it made additional recommendations that are relevant for our healthcare system’s response to, and responsibility for, any patient safety issues.
